Benign prostatic hyperplasia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Repeated urinary retention (unable to urinate after at least one extubation or urinary retention twice); (2) Recurrent hematuria, 5 a- Reductase inhibitors are ineffective in treatment; (3) Repeated urinary tract infections with concurrent bladder stones; (4) Secondary upper urinary tract hydronephrosis (with or without renal dysfunction), benign prostate patients with bladder diverticulum, inguinal hernia, severe hemorrhoids or prolapse.
Exclusion criteria
Exclusion criteria: (1) Qmax > 20ml/s; (2) Neurogenic bladder dysfunction; (3) A history of lower urinary tract injury or previous prostate or urethral surgery; (4) Previous history of prostate cancer; (5) Urethral stenosis or bladder neck contracture;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1 Month Postoperatively International Prostate Symptom Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of urinary incontinence after extubation;Bladder irrigation time;Retention catheterization time;Postoperative hospitalization time;IPSS score;Quality of life score;Maximum urinary flow rate;Residual urine volume; | — |
Countries
China
Contacts
Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine